Emisphere Technologies Inc (EMIS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Emisphere Technologies Inc stock (EMIS) is currently trading at $10.03. Emisphere Technologies Inc PS ratio (Price-to-Sales) is 457.16. Analyst consensus price target for EMIS is $0.75. WallStSmart rates EMIS as Sell.
- EMIS PE ratio analysis and historical PE chart
- EMIS PS ratio (Price-to-Sales) history and trend
- EMIS intrinsic value — DCF, Graham Number, EPV models
- EMIS stock price prediction 2025 2026 2027 2028 2029 2030
- EMIS fair value vs current price
- EMIS insider transactions and insider buying
- Is EMIS undervalued or overvalued?
- Emisphere Technologies Inc financial analysis — revenue, earnings, cash flow
- EMIS Piotroski F-Score and Altman Z-Score
- EMIS analyst price target and Smart Rating
Emisphere Technologies Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Emisphere Technologies Inc (EMIS) · 6 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Concerns around operating margin and price/sales. Significant fundamental concerns warrant caution or avoidance.
Emisphere Technologies Inc (EMIS) Key Strengths (0)
Emisphere Technologies Inc (EMIS) Areas to Watch (6)
Losing money on operations
Revenue declining -40.50%, a shrinking business
Company is losing money with a negative profit margin
Very expensive at 457.2x annual revenue
Very low institutional interest at 0.09%
Small-cap company with higher risk but more growth potential
Supporting Valuation Data
Emisphere Technologies Inc (EMIS) Detailed Analysis Report
Overall Assessment
This company scores 8/100 in our Smart Analysis, earning a F grade. Out of 6 metrics analyzed, 0 register as strengths (avg 0/10) while 6 fall into concern territory (avg 1.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
Limited fundamental strengths were identified. The bull case requires improvement in core metrics.
The Bear Case
The primary concerns are Operating Margin, Revenue Growth, Profit Margin. Some valuation metrics including Price/Sales (457.16) suggest expensive pricing. Growth concerns include Revenue Growth at -40.50%, which may limit upside. Profitability pressure is visible in Operating Margin at -596.00%, Profit Margin at -205.80%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Operating Margin at -596.00% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -40.50% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Operating Margin and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
EMIS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
EMIS's Price-to-Sales ratio of 457.16x sits near its historical average of 478.89x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 11% below its historical high of 512.28x set in Jan 2026, and 0% above its historical low of 457.16x in Feb 2026.
Compare EMIS with Competitors
Top DRUG MANUFACTURERS - SPECIALTY & GENERIC stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Emisphere Technologies Inc (EMIS) · HEALTHCARE › DRUG MANUFACTURERS - SPECIALTY & GENERIC
The Big Picture
Emisphere Technologies Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 1M with 41% decline year-over-year. The company is currently unprofitable, posting a -205.8% profit margin.
Key Findings
Revenue contracted 41% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -205.8% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Sector dynamics: monitor DRUG MANUFACTURERS - SPECIALTY & GENERIC industry trends, competitive moves, and regulatory changes that could impact Emisphere Technologies Inc.
Bottom Line
Emisphere Technologies Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Emisphere Technologies Inc(EMIS)
OTCBB
HEALTHCARE
DRUG MANUFACTURERS - SPECIALT...
USA
Emisphere Technologies, Inc. is a commercial stage pharmaceutical and drug delivery company in the United States. The company is headquartered in Roseland, New Jersey.